Live data from Hacker News

The neuroinvasive potential of SARS-CoV2

ncbi.nlm.nih.gov

11–20 of 298 posts

Re: The neuroinvasive potential of SARS-CoV2

#12

I thought papers dealing with this virus were to be made available publicly?

go here:

https://sci-hub.se/10.1002/jmv.25728

keep in mind this is a preliminary, the grammar used in this paper needs to be revised so as to avoid as much as possible, people coming to errant conclusions after misinterpreting poorly written phrases.

so that means that while reading this paper one should not skim but should take the effort to interpret this paper.

there is an absence of references in the abstract, this makes it hard to examine the basis for statements in abstract

Re: The neuroinvasive potential of SARS-CoV2

#13

If it did turn out this virus is neuroinvasive and that is what causes acute respiratory problems, how would this be prevented/mitigated/treated, theoretically?

> Considering the potential neuroinvasion of SARS-CoV-2, antiviral therapy should be carried out as early as possible to block its entry into the CNS. Airway inhalation of antiviral agents will be the first choice at the early stage of infection, which will inhibit the replication SARS-CoV-2 in the respiratory tracts and lung and prevent from its subsequent neuroinvasion. It is also urgent to find effective antiviral drugs that can cross the blood-brain barrier. Moreover, corticosteroids, which are used frequently for severe patients, may have no treatment effect, but rather accelerate the replication of the virus within the neurons.

Re: The neuroinvasive potential of SARS-CoV2

#15
post #10

From the paper: > If the neuroinvasion of SARS-CoV-2 does take a part in the development of respiratory failure in COVID-19 patients, the precaution with masks will absolutely be the most effective measure to protect against the possible entry of the virus into the CNS. It may also be expected that the symptoms of the patients infected via facal-oral or conjunctival route will be lighter than those infected intranasa…

Yes, only a N95 or better mask would protect you from incoming, as opposed to outgoing, viruses, and these masks are both impractical for everyday wear and need to be conserved for public health users.

Re: The neuroinvasive potential of SARS-CoV2

#16
post #10

From the paper: > If the neuroinvasion of SARS-CoV-2 does take a part in the development of respiratory failure in COVID-19 patients, the precaution with masks will absolutely be the most effective measure to protect against the possible entry of the virus into the CNS. It may also be expected that the symptoms of the patients infected via facal-oral or conjunctival route will be lighter than those infected intranasa…

How often would people have to replace their N95s to be of help?

Re: The neuroinvasive potential of SARS-CoV2

#17
post #10

From the paper: > If the neuroinvasion of SARS-CoV-2 does take a part in the development of respiratory failure in COVID-19 patients, the precaution with masks will absolutely be the most effective measure to protect against the possible entry of the virus into the CNS. It may also be expected that the symptoms of the patients infected via facal-oral or conjunctival route will be lighter than those infected intranasa…

Yes, only a N95 or better mask would protect you from incoming, as opposed to outgoing, viruses, and these masks are both impractical for everyday wear and need to be conserved for public health users.

I have a small box of N95 masks in my shop - bought last summer for dust protection. When is the right time for me to put them on my family. Part of this is how long will they last before I must replace them. Or should I put them on eBay for a million dollars and hope I life to enjoy my new found wealth?

Re: The neuroinvasive potential of SARS-CoV2

#18
Not a biologist, but reading the paper, the chain of reasoning appears to be summarized in this section:

> Taken together, the neuroinvasive propensity has been demonstrated as a common feature of CoVs. In light of the high similarity between SARS-CoV and SARS-CoV2, it is quite likely that SARS-CoV-2 also possesses a similar potential. Based on an epidemiological survey on COVID-19, the median time from the first symptom to dyspnea was 5.0 days, to hospital admission was 7.0 days, and to the intensive care was 8.0 days 15. Therefore, the latency period is enough for the virus to enter and destroy the medullary neurons. As a matter of fact, it has been reported that some patients infected with SARS-CoV-2 did show neurologic signs such as headache (about 8%), nausea and vomiting (1%).

There's also this rather disquieting anecdote used as evidence of a link to the nervous system:

> According to the complaints of a survivor, the medical graduate student (24 years old) from Wuhan University, she must stay awake and breathe consciously and actively during the intensive care. She said that if she fell asleep, she might die because she had lost her natural breath.

Supposing that this neurological link is real,

> the precaution with masks will absolutely be the most effective measure to protect against the possible entry of the virus into the CNS. It may also be expected that the symptoms of the patients infected via facal-oral [sic?] or conjunctival route will be lighter than those infected intranasally. The possible neuroinvasion of SARS-CoV-2 may also partially explain why some patients developed respiratory failure, while others not. It is very possible that most of the persons in Wuhan, who were the first exposed to this previously unknown virus, did not have any protective measure, so that the critical patients is much more in Wuhan than in other cities in China.

So let me ask a dumb question for someone with actual biomedical knowledge. Are they saying that infection of the CNS is somehow easier through the nose, in which case high-quality face masks actually do matter?

I'm also confused by this sentence in the introduction, which appears to contradict the hypothesis that the upper respiratory tract is a high-impact area?

> However, different from SARS-CoV, SARS-CoV-2-infected patients rarely showed prominent upper respiratory tract signs and symptoms, indicating that the target cells of SARS-CoV-2 may be located in the lower airway.

I will note that, unlike some other papers on this topic, this one has been peer-reviewed in what seems to be a legitimate medical journal (Journal of Medical Virology), so there should be some genuine substance here.

Re: The neuroinvasive potential of SARS-CoV2

#19
post #16
post #10

From the paper: > If the neuroinvasion of SARS-CoV-2 does take a part in the development of respiratory failure in COVID-19 patients, the precaution with masks will absolutely be the most effective measure to protect against the possible entry of the virus into the CNS. It may also be expected that the symptoms of the patients infected via facal-oral or conjunctival route will be lighter than those infected intranasa…

How often would people have to replace their N95s to be of help?

It looks like CDC recommends to use them for ≤ 8 hours (continuous or intermittent) [0].

[0] https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguid...

Re: The neuroinvasive potential of SARS-CoV2

#20
post #10

From the paper: > If the neuroinvasion of SARS-CoV-2 does take a part in the development of respiratory failure in COVID-19 patients, the precaution with masks will absolutely be the most effective measure to protect against the possible entry of the virus into the CNS. It may also be expected that the symptoms of the patients infected via facal-oral or conjunctival route will be lighter than those infected intranasa…

This suggests an advantage to purposeful infection by oral/eye rather than accidental by intranasal. It'll be interesting to see what the case fatality rate is when segmented by infection route.
Post reply on HN